Check out the companies that made headlines in midday trading: Nvidia — The chipmaker reversed earlier gains and fell nearly 2% after reporting better-than-expected third-quarter results. Nvidia’s fourth-quarter earnings outlook was also stronger than analysts expected. Amid Nvida’s stock slump, many other AI trades also fell, including Palantir Technologies, which fell nearly 6%, and AMD and Super Micro Computers, each down about 5%. Exact Sciences — Abbott Laboratories, the maker of Cologuard, a diagnostic test that detects colorectal cancer, soared 17% after it agreed to a $105-per-share cash acquisition worth about $21 billion. The deal is expected to close in the second quarter of 2026, and Abbott fell 1%. Cryptocurrency Stocks — Stocks related to cryptocurrencies fell as the value of Bitcoin continued to fall on Thursday amid expectations for interest rate cuts. Bitcoin treasury firm Strategy fell nearly 7%, trading platform Robinhood Markets fell about 9% and Coinbase fell 7%. Stablecoin company Circle Internet fell nearly 6%. Regeneron — The drug company’s stock soared 4% after the company announced that the Food and Drug Administration approved Eylea HD for the treatment of macular edema following retinal vein occlusion. Walmart — Retail giant Walmart posted third-quarter results that beat expectations by nearly 6%. Walmart earned an adjusted 62 cents per share on revenue of $179.5 billion. Analysts had expected sales of $177.43 billion and earnings per share of 60 cents. The company also raised its full-year sales forecast. Palo Alto Networks — Cybersecurity stocks fell more than 6% after the company announced it would acquire cloud management company Chronosphere for $3.35 billion. This overshadowed Palo Alto Networks’ better-than-expected fiscal first quarter results. Oddity — The beauty and wellness company’s stock rose 11% after third-quarter numbers that beat analysts’ expectations. Oddity earned 40 cents a share, excluding certain items, on revenue of $148 million. Analysts polled by LSEG had expected sales of $145 million and earnings of 35 cents per share. The company also raised its full-year profit forecast. Jacobs Solutions — The engineering and construction services company fell 9% despite fourth-quarter profits beating the Street. Jacobs Solutions earned $1.75 per share, excluding certain items, compared with analyst estimates compiled by FactSet of $1.68 per share. The company’s forecast for fiscal 2026 also exceeded expectations. Solventum — Shares of the healthcare company rose 4% after the company announced it would acquire Acela Surgical for $725 million in cash. This agreement will allow Solventum to enter the regenerative wound treatment market. Bath & Body Works — The U.S. soap and lotion retailer fell more than 25% after disappointing third-quarter results. Adjusted earnings per share were 35 cents, below analysts’ expectations of 39 cents per share, according to FactSet. Revenue was $1.59 billion, below the consensus estimate of $1.63 billion. —CNBC’s Fred Imbert and Sarah Min contributed to this report.
